Search results
Results from the WOW.Com Content Network
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. [4] Organon specializes in the following core therapeutic fields: reproductive medicine , contraception , psychiatry , hormone replacement therapy (HRT), and anesthesia .
The company posted quarterly revenue of $1.61 billion, beating analysts' average estimate of $1.57 billion. "In the United States, the Dobbs decision has driven an increase in demand from patients ...
A contraceptive implant is an implantable medical device used for the purpose of birth control. The implant may depend on the timed release of hormones to hinder ovulation or sperm development, the ability of copper to act as a natural spermicide within the uterus , or it may work using a non-hormonal, physical blocking mechanism.
Etonogestrel birth control implants are a type of long-acting reversible contraception, which has been shown to be one of the most effective form of birth control. [22] The failure rate of the implants is 0.05% for both perfect use and typical use because the method requires no user action after placement. [23]
Modern contraceptives using steroid hormones have perfect-use or method failure rates of less than 1% per year. The lowest failure rates are seen with the implants Jadelle and Implanon, at 0.05% per year. [9] [10] According to Contraceptive Technology, none of these methods has a failure rate greater than 0.3% per year. [10]
Male contraceptives, also known as male birth control, are methods of preventing pregnancy by interrupting the function of sperm. [1] The main forms of male contraception available today are condoms , vasectomy , and withdrawal , which together represented 20% of global contraceptive use in 2019.
This is a list of progestogens (progesterone and progestins) and formulations that are approved by the FDA Tooltip Food and Drug Administration in the United States. . Progestogens are used as hormonal contraceptives, in hormone replacement therapy for menopausal symptoms, and in the treatment of gynecological
The vaginal ring with ethinylestradiol and etonogestrel increases the risk of venous blood clots 6.5 times compared to non-users of hormonal birth control. [20] This is similar to the risk of blood clots with combination birth control pills, which range between 3 times to 14 times the risk. [29]